194 related articles for article (PubMed ID: 35536256)
1. Control of bacterial immune signaling by a WYL domain transcription factor.
Blankenchip CL; Nguyen JV; Lau RK; Ye Q; Gu Y; Corbett KD
Nucleic Acids Res; 2022 May; 50(9):5239-5250. PubMed ID: 35536256
[TBL] [Abstract][Full Text] [Related]
2. Structure and activity of a bacterial defense-associated 3'-5' exonuclease.
Liang Q; Richey ST; Ur SN; Ye Q; Lau RK; Corbett KD
Protein Sci; 2022 Jul; 31(7):e4374. PubMed ID: 35762727
[TBL] [Abstract][Full Text] [Related]
3. A widespread family of WYL-domain transcriptional regulators co-localizes with diverse phage defence systems and islands.
Picton DM; Harling-Lee JD; Duffner SJ; Went SC; Morgan RD; Hinton JCD; Blower TR
Nucleic Acids Res; 2022 May; 50(9):5191-5207. PubMed ID: 35544231
[TBL] [Abstract][Full Text] [Related]
4. The arms race between bacteria CBASS and bacteriophages.
Wang L; Zhang L
Front Immunol; 2023; 14():1224341. PubMed ID: 37575224
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the WYL BrxR protein and its gene as separable regulatory elements of a BREX phage restriction system.
Luyten YA; Hausman DE; Young JC; Doyle LA; Higashi KM; Ubilla-Rodriguez NC; Lambert AR; Arroyo CS; Forsberg KJ; Morgan RD; Stoddard BL; Kaiser BK
Nucleic Acids Res; 2022 May; 50(9):5171-5190. PubMed ID: 35511079
[TBL] [Abstract][Full Text] [Related]
6. Diversity and classification of cyclic-oligonucleotide-based anti-phage signalling systems.
Millman A; Melamed S; Amitai G; Sorek R
Nat Microbiol; 2020 Dec; 5(12):1608-1615. PubMed ID: 32839535
[TBL] [Abstract][Full Text] [Related]
7. A conserved signaling pathway activates bacterial CBASS immune signaling in response to DNA damage.
Lau RK; Enustun E; Gu Y; Nguyen JV; Corbett KD
EMBO J; 2022 Nov; 41(22):e111540. PubMed ID: 36156805
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophages inhibit and evade cGAS-like immune function in bacteria.
Huiting E; Cao X; Ren J; Athukoralage JS; Luo Z; Silas S; An N; Carion H; Zhou Y; Fraser JS; Feng Y; Bondy-Denomy J
Cell; 2023 Feb; 186(4):864-876.e21. PubMed ID: 36750095
[TBL] [Abstract][Full Text] [Related]
9. Effector-mediated membrane disruption controls cell death in CBASS antiphage defense.
Duncan-Lowey B; McNamara-Bordewick NK; Tal N; Sorek R; Kranzusch PJ
Mol Cell; 2021 Dec; 81(24):5039-5051.e5. PubMed ID: 34784509
[TBL] [Abstract][Full Text] [Related]
10. Activation of a
Severin GB; Ramliden MS; Ford KC; Van Alst AJ; Sanath-Kumar R; Decker KA; Hsueh BY; Chen G; Yoon SH; Demey LM; O'Hara BJ; Rhoades CR; DiRita VJ; Ng W-L; Waters CM
mBio; 2023 Oct; 14(5):e0087523. PubMed ID: 37623317
[TBL] [Abstract][Full Text] [Related]
11. Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides.
Cao X; Xiao Y; Huiting E; Cao X; Li D; Ren J; Fedorova I; Wang H; Guan L; Wang Y; Li L; Bondy-Denomy J; Feng Y
Mol Cell; 2024 Jan; 84(2):375-385.e7. PubMed ID: 38103556
[TBL] [Abstract][Full Text] [Related]
12. Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy.
Lopatina A; Tal N; Sorek R
Annu Rev Virol; 2020 Sep; 7(1):371-384. PubMed ID: 32559405
[TBL] [Abstract][Full Text] [Related]
13. CBASS Immunity Uses CARF-Related Effectors to Sense 3'-5'- and 2'-5'-Linked Cyclic Oligonucleotide Signals and Protect Bacteria from Phage Infection.
Lowey B; Whiteley AT; Keszei AFA; Morehouse BR; Mathews IT; Antine SP; Cabrera VJ; Kashin D; Niemann P; Jain M; Schwede F; Mekalanos JJ; Shao S; Lee ASY; Kranzusch PJ
Cell; 2020 Jul; 182(1):38-49.e17. PubMed ID: 32544385
[TBL] [Abstract][Full Text] [Related]
14. Phage anti-CBASS and anti-Pycsar nucleases subvert bacterial immunity.
Hobbs SJ; Wein T; Lu A; Morehouse BR; Schnabel J; Leavitt A; Yirmiya E; Sorek R; Kranzusch PJ
Nature; 2022 May; 605(7910):522-526. PubMed ID: 35395152
[TBL] [Abstract][Full Text] [Related]
15. Convergent mutations in phage virion assembly proteins enable evasion of Type I CBASS immunity.
Richmond-Buccola D; Hobbs SJ; Garcia JM; Toyoda H; Gao J; Shao S; Lee ASY; Kranzusch PJ
bioRxiv; 2023 May; ():. PubMed ID: 37292831
[TBL] [Abstract][Full Text] [Related]
16. CBASS phage defense and evolution of antiviral nucleotide signaling.
Duncan-Lowey B; Kranzusch PJ
Curr Opin Immunol; 2022 Feb; 74():156-163. PubMed ID: 35123147
[TBL] [Abstract][Full Text] [Related]
17. Specific recognition of cyclic oligonucleotides by Cap4 for phage infection.
Chang JJ; You BJ; Tien N; Wang YC; Yang CS; Hou MH; Chen Y
Int J Biol Macromol; 2023 May; 237():123656. PubMed ID: 36796558
[TBL] [Abstract][Full Text] [Related]
18. A large-scale type I CBASS antiphage screen identifies the phage prohead protease as a key determinant of immune activation and evasion.
Richmond-Buccola D; Hobbs SJ; Garcia JM; Toyoda H; Gao J; Shao S; Lee ASY; Kranzusch PJ
Cell Host Microbe; 2024 Jun; ():. PubMed ID: 38917809
[TBL] [Abstract][Full Text] [Related]
19. Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides.
Cao X; Xiao Y; Huiting E; Cao X; Li D; Ren J; Guan L; Wang Y; Li L; Bondy-Denomy J; Feng Y
bioRxiv; 2023 Jun; ():. PubMed ID: 37398474
[TBL] [Abstract][Full Text] [Related]
20. Microbial Arsenal of Antiviral Defenses. Part II.
Isaev AB; Musharova OS; Severinov KV
Biochemistry (Mosc); 2021 Apr; 86(4):449-470. PubMed ID: 33941066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
